Physician profile
Michael L Mcgrattan
NPI 1366885634
$895.80
in general payments reported to CMS, 2019-2025
13 companies · $47.32 in 2025
The $47.32 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $167 · 2021: $179 · 2022: $21.24 · 2023: $66.39 · 2024: $24.72 · 2025: $47.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $138.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $260.10 | 2019 | |
| Janssen Pharmaceuticals, INC | $216.45 | 2019-2022 | |
| Kci USA, INC. | $82.43 | 2019 | |
| Intuitive Surgical, INC. | $74.38 | 2020-2023 | Da Vinci Surgical System |
| Advanced Oxygen Therapy INC. | $46.20 | 2023-2024 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Smith+Nephew, INC. | $44.57 | 2019-2020 | |
| Venclose INC. | $39.11 | 2020 | |
| Mimedx Group, INC. | $26.12 | 2025 | |
| Convatec INC. | $23.42 | 2023 | |
| Medtronic, INC. | $22.71 | 2021 | |
| Davol INC. | $21.20 | 2025 | Phasix Mesh |
| Pfizer INC. | $20.72 | 2021 | |
| Integra Lifesciences Corporation | $18.39 | 2023 | Tcc-Ez |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mcgrattan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.